News
At Retina World Congress 2025, Dilsher S. Dhoot, MD, shares updates on the HELIOS trial and the potential future of tyrosine ...
Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...
RWC 2025: Katherine Talcott, MD, discusses the potential connection of auto-immune conditions to AMD
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Glaucoma management is shifting toward earlier, drop-sparing interventions using sustained drug delivery and advanced laser ...
Biotechnology company Optigo Biotherapeutics received the People’s Choice Award at the 2025 Eyecelerator meeting for the ...
Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic ...
Beacon Therapeutics reveals promising interim results for laru-zova, a gene therapy showing potential to improve vision in ...
Topcon Healthcare launches IDHea, an innovative platform enhancing AI research and ocular data access to improve clinical ...
Machine learning algorithms enhance retinopathy of prematurity screening using smartphone images, expanding access in ...
A one-drop, low dose atropine study assesses accommodative amplitude and dynamics, with clinically applicable findings.
A study reveals that repeated anti-VEGF injections for AMD do not alter retinal vascular metrics over time, ensuring ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results